Deal Intelligence Platform & Services for Global M&A / PE
2021 brought a flurry of #MnA activity in the life sciences sector, followed by a slowdown in 2022. Here’s why dealmaking could pick up again. deloi.tt/3PIOHZP
– Deloitte M&A (@DeloitteMnA)09:00 – Aug 31, 2022
BlackRock entered an agreement on October 13, 2026, to acquire the majority equity stake in a primary care joint venture from Welsh, Carson, Anderson & Stowe for $2.8 billion. The transaction...
STERIS Corporation, a wholly owned operating subsidiary of STERIS plc, agreed to buy Xodus Medical, Inc. for $2.1 billion in cash on October 12, 2026, according to a corporate press release...
Viatris Inc. agreed to purchase Pacira BioSciences Inc. for $36.50 per share in cash on October 8, 2026, establishing an equity valuation of approximately $1.65 billion. The transaction establishes...
Shionogi & Co., Ltd. agreed to acquire IntraBio Inc. for $2.0 billion in an all-cash transaction announced on October 5, 2026. The Japanese pharmaceutical company will purchase 100 percent of the...